Pfizer Inc.: Drug Recall
Recall #D-0873-2022 · 04/22/2022
Class II: Risk
Recall Details
- Recall Number
- D-0873-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Pfizer Inc.
- Status
- Terminated
- Date Initiated
- 04/22/2022
- Location
- New York, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,304 bottles
Reason for Recall
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Product Description
Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Distribution Pattern
Nationwide and Puerto Rico
Other Recalls by Pfizer Inc.
- Class II: Risk 08/04/2025
- Class II: Risk 08/04/2025
- Class II: Risk 07/10/2025
- Class II: Risk 07/10/2025
- Class II: Risk 05/28/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.